Stock Groups

Illumina Earnings, Revenue Beat in Q4 -Breaking

by Mike Robinson

[ad_1]

© Reuters. Illumina Earnings, Revenue Beat in Q4

Illumina (NASDAQ) reported Thursday that the fourth quarter beat analyst forecasts, and that revenue exceeded expectations.

Illumina reported earnings per share at $0.75 on $1.2B in revenue. Investing.com polled analysts and predicted EPS at $0.4562 for revenue of $1.13B.

Illumina shares have fallen 5.88% since the start of the year. However, they are still 35.57% below the 52-week high of $555.77 on February 12, 2021. They are broadly in line with the S&P 500 which is down 5.52% from the start of the year.

Following the publication, Illumina shares gained 1.3% in post-hours trade.

Illumina’s earnings are in line with other healthcare sector leaders this month

Illumina’s earnings beat was achieved by UnitedHealth in January 19. They reported an EPS of 4.48 for revenue $73.74B. This compares to the forecasts of EPS $4.3 for revenue $72.98B.

J&J had beat expectations on January 25 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.

Keep up to date with all the earnings reports coming soon by visiting Investing.com’s earnings calendar

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this website’s data including quotes and charts. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]